Angelika Eggert

Berlin, BE 13353, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 222 publications

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Journal: The Journal of clinical investigation

Published: February 12, 2026

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Journal: Bone marrow transplantation

Published: January 18, 2026

Viscoelastic profiling of rare pediatric extracranial tumors using multifrequency MR elastography: a pilot study.

Viscoelastic profiling of rare pediatric extracranial tumors using multifrequency MR elastography: a pilot study.

Journal: Scientific reports

Published: January 01, 2026

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

Journal: The oncologist

Published: December 23, 2025

Current treatment strategies for first relapse of high-risk neuroblastoma.

Current treatment strategies for first relapse of high-risk neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 16, 2025

Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.

Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.

Journal: Radiology. Imaging cancer

Published: December 12, 2025

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Journal: Cancers

Published: December 10, 2025

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Journal: Cancer research

Published: November 19, 2025

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Journal: Molecular oncology

Published: October 31, 2025

Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche.

Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche.

Journal: Cancer letters

Published: October 08, 2025

circVDJ-seq for T cell clonotype detection in single-cell and spatial multi-omics.

circVDJ-seq for T cell clonotype detection in single-cell and spatial multi-omics.

Journal: Genome medicine

Published: September 05, 2025

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Journal: Frontiers in immunology

Published: July 31, 2025

Showing 1-12 of 222

Last Updated: 09/26/2026